search
Back to results

Avaulta Versus Anterior Repair

Primary Purpose

Vaginal Prolapse

Status
Unknown status
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Avaulta (surgical procedure using a mesh implant)
Conventional surgery (anterior repair)
Sponsored by
Zealand University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional trial for Vaginal Prolapse focused on measuring cystocele, anterior repair, mesh

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Women aged > 55 yr
  • Women with anterior vaginal wall prolapse stage >2 according to POP-Q classification
  • Good understanding the language in word and writing

Exclusion Criteria:

  • A history of previous major pelvic surgery with the exception of a hysterectomy for reasons other than genital prolapse
  • Patients with previous vaginal surgery because of defects in the anterior of posterior compartments
  • Previous hysterectomy because of vaginal prolapse
  • Patients with prolapse of uterus or an enterocele > stage 2
  • Patients with previous TVT performed through the obturator membrane
  • History of genital or abdominal cancer
  • Patients treated with corticosteroids
  • Not able to understand the study protocol (language problems, cognitive dysfunction etc.)

Sites / Locations

  • Roskilde University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

1

2

Arm Description

Outcomes

Primary Outcome Measures

Does Avaulta Plus reduce the recurrence rate defined as a POP-Q Aa <-2 cm at follow-up after 1 yr.

Secondary Outcome Measures

Full Information

First Posted
February 22, 2008
Last Updated
February 29, 2008
Sponsor
Zealand University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT00627549
Brief Title
Avaulta Versus Anterior Repair
Official Title
The Use of Avaulta Plus for Anterior Repair. A Multicenter Randomised Prospective Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
February 2008
Overall Recruitment Status
Unknown status
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Zealand University Hospital

4. Oversight

5. Study Description

Brief Summary
Summary: Vaginal prolapse is a well-known disease and is observed in approximately 11% of all postmenopausal women and tending to increase with age. Consequently, many surgical procedures have been developed in order to ensure sufficient support for the bladder, rectum or vaginal vault depending on the site of the defect. However, many procedures are associated with a high recurrence rate up to 40 % even within one to two years after the surgical procedure. Due to the high recurrence rate new methods include the use of mesh, either biologically or synthetic. The latter is a permanent implant and therefore theoretically may result in a long-lasting anatomically correct position of the prolapse. Although the recurrence rate may be lower using a mesh such surgical procedures may be associated with adverse events such as erosions of the vaginal mucosa. Others have observed shrinkage of the vaginal mucosa. However, in these studies large prolene mesh have been used. In contrast the recurrence rate is lowered up to 25%. The above-mentioned advantage of synthetic mesh is however, mostly based on few non-randomised studies. We therefore find it of importance to evaluate whether a surgical procedure using a mesh implant is superior to conventional surgical techniques. The present study is a clinical controlled study where patients with anterior vaginal prolapse are randomised to either a mesh technique or a standard anterior procedure. The present study includes only two more visits at the outpatient clinic after the surgical procedure. Furthermore the patients have to fulfil questionnaires regarding urinary and faecal leakage and sexual habits. Any participation in the study is totally voluntary and the patient may at any time withdraw herself. In any case the patient will receive our standard treatment. The study is performed in all the Scandinavian countries.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vaginal Prolapse
Keywords
cystocele, anterior repair, mesh

7. Study Design

Study Phase
Not Applicable

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Title
2
Arm Type
Active Comparator
Intervention Type
Procedure
Intervention Name(s)
Avaulta (surgical procedure using a mesh implant)
Intervention Description
The use of Avaulta
Intervention Type
Procedure
Intervention Name(s)
Conventional surgery (anterior repair)
Intervention Description
Anterior repair surgery
Primary Outcome Measure Information:
Title
Does Avaulta Plus reduce the recurrence rate defined as a POP-Q Aa <-2 cm at follow-up after 1 yr.
Time Frame
one year

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women aged > 55 yr Women with anterior vaginal wall prolapse stage >2 according to POP-Q classification Good understanding the language in word and writing Exclusion Criteria: A history of previous major pelvic surgery with the exception of a hysterectomy for reasons other than genital prolapse Patients with previous vaginal surgery because of defects in the anterior of posterior compartments Previous hysterectomy because of vaginal prolapse Patients with prolapse of uterus or an enterocele > stage 2 Patients with previous TVT performed through the obturator membrane History of genital or abdominal cancer Patients treated with corticosteroids Not able to understand the study protocol (language problems, cognitive dysfunction etc.)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Martin Rudnicki, professor
Phone
+4547324007
Facility Information:
Facility Name
Roskilde University Hospital
City
Roskilde
ZIP/Postal Code
4000
Country
Denmark
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Martin Rudnicki, Professor
First Name & Middle Initial & Last Name & Degree
Ulla Hviid, MD
First Name & Middle Initial & Last Name & Degree
Martin Rudnicki, Professor

12. IPD Sharing Statement

Citations:
PubMed Identifier
26420345
Citation
Rudnicki M, Laurikainen E, Pogosean R, Kinne I, Jakobsson U, Teleman P. A 3-year follow-up after anterior colporrhaphy compared with collagen-coated transvaginal mesh for anterior vaginal wall prolapse: a randomised controlled trial. BJOG. 2016 Jan;123(1):136-42. doi: 10.1111/1471-0528.13628. Epub 2015 Sep 30.
Results Reference
derived
PubMed Identifier
24866279
Citation
Teleman P, Laurikainen E, Kinne I, Pogosean R, Jakobsson U, Rudnicki M. Relationship between the Pelvic Organ Prolapse Quantification system (POP-Q), the Pelvic Floor Impact Questionnaire (PFIQ-7), and the Pelvic Floor Distress Inventory (PFDI-20) before and after anterior vaginal wall prolapse surgery. Int Urogynecol J. 2015 Feb;26(2):195-200. doi: 10.1007/s00192-014-2434-6. Epub 2014 May 28.
Results Reference
derived
PubMed Identifier
24118844
Citation
Rudnicki M, Laurikainen E, Pogosean R, Kinne I, Jakobsson U, Teleman P. Anterior colporrhaphy compared with collagen-coated transvaginal mesh for anterior vaginal wall prolapse: a randomised controlled trial. BJOG. 2014 Jan;121(1):102-10; discussion 110-1. doi: 10.1111/1471-0528.12454. Epub 2013 Oct 1.
Results Reference
derived

Learn more about this trial

Avaulta Versus Anterior Repair

We'll reach out to this number within 24 hrs